Literature DB >> 25714180

Outpatient oral treatment for acute promyelocytic leukemia.

Hong-Hu Zhu1, Xiao-Jun Huang1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25714180     DOI： 10.1056/NEJMc1500125

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Combining retinoic acid and oral arsenic may be potentially the first-line therapy for non-high-risk acute promyelocytic leukemia.

Authors:  Lin Fu; Jinlong Shi; Jia Liu; Anqi Liu; Kailin Xu; Xiaoyan Ke
Journal:  Stem Cell Investig       Date:  2016-12-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.